Financials Aier Eye Hospital Group Co., Ltd.
Equities
300015
CNE100000GR6
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.530 CNY | +2.36% | -1.75% | -39.76% |
26/08 | Citi Downgrades Aier Eye Hospital Group to Sell From Neutral; Price Target is 7 Yuan | MT |
26/08 | Aier Eye Hospital Group H1 Profit Up 20%, Operating Income Rises 3% | MT |
Projected Income Statement: Aier Eye Hospital Group Co., Ltd.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 9,990 | 11,912 | 15,001 | 16,110 | 20,367 | 21,908 | 25,537 | 29,401 |
Change | - | 19.24% | 25.93% | 7.39% | 26.43% | 7.57% | 16.56% | 15.13% |
EBITDA 1 | 2,526 | 3,225 | 4,156 | - | 5,954 | 6,439 | 7,595 | 8,629 |
Change | - | 27.64% | 28.9% | -100% | - | 8.14% | 17.96% | 13.61% |
EBIT 1 | 2,022 | 2,674 | 3,494 | 3,534 | 4,948 | 5,524 | 6,511 | 7,638 |
Change | - | 32.26% | 30.66% | 1.16% | 39.99% | 11.65% | 17.87% | 17.3% |
Interest Paid 1 | -75.53 | -90.35 | -106.4 | -6.655 | -73.63 | -70.39 | -83.32 | -99.11 |
Earnings before Tax (EBT) 1 | 1,840 | 2,363 | 3,148 | 3,335 | 4,551 | 5,279 | 6,209 | 7,351 |
Change | - | 28.42% | 33.19% | 5.95% | 36.46% | 15.99% | 17.63% | 18.4% |
Net income 1 | 1,379 | 1,724 | 2,323 | 2,524 | 3,359 | 3,937 | 4,595 | 5,438 |
Change | - | 25.01% | 34.78% | 8.65% | 33.07% | 17.22% | 16.69% | 18.36% |
Announcement Date | 28/02/20 | 22/04/21 | 25/04/22 | 25/04/23 | 25/04/24 | - | - | - |
Forecast Balance Sheet: Aier Eye Hospital Group Co., Ltd.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 685 | -981 | -2,024 | -4,777 | -4,458 | -7,996 | -10,778 | -13,894 |
Change | - | -243.21% | -306.32% | -336.02% | -193.32% | -279.34% | -234.79% | -228.91% |
Announcement Date | 28/02/20 | 22/04/21 | 25/04/22 | 25/04/23 | 25/04/24 | - | - | - |
Cash Flow Forecast: Aier Eye Hospital Group Co., Ltd.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 739.7 | 888.3 | 1,488 | 1,380 | 1,454 | 1,515 | 1,510 | 1,333 |
Change | - | 20.09% | 67.49% | -7.21% | 5.34% | 4.18% | -0.32% | -11.74% |
Free Cash Flow (FCF) 1 | 1,339 | 2,455 | 2,596 | 3,110 | 4,418 | 5,155 | 4,556 | 5,417 |
Change | - | 83.41% | 5.74% | 19.79% | 42.04% | 16.69% | -11.62% | 18.91% |
Announcement Date | 28/02/20 | 22/04/21 | 25/04/22 | 25/04/23 | 25/04/24 | - | - | - |
Forecast Financial Ratios: Aier Eye Hospital Group Co., Ltd.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 25.29% | 27.07% | 27.71% | - | 29.23% | 29.39% | 29.74% | 29.35% |
EBIT Margin (%) | 20.24% | 22.45% | 23.29% | 21.94% | 24.29% | 25.22% | 25.5% | 25.98% |
EBT Margin (%) | 18.42% | 19.84% | 20.98% | 20.7% | 22.34% | 24.09% | 24.31% | 25% |
Net margin (%) | 13.8% | 14.47% | 15.49% | 15.67% | 16.49% | 17.97% | 17.99% | 18.5% |
FCF margin (%) | 13.4% | 20.61% | 17.31% | 19.31% | 21.69% | 23.53% | 17.84% | 18.43% |
FCF / Net Income (%) | 97.09% | 142.44% | 111.75% | 123.22% | 131.52% | 130.93% | 99.16% | 99.62% |
Profitability | ||||||||
ROA | 12.81% | 12.57% | 12.43% | - | 11.83% | 12.58% | 12.66% | 12.69% |
ROE | 22.51% | 21.48% | 20.58% | 19.16% | 18.88% | 18.72% | 18.92% | 19.01% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | 0.27x | - | - | - | - | - | - | - |
Debt / Free cash flow | 0.51x | - | - | - | - | - | - | - |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 7.4% | 7.46% | 9.92% | 8.57% | 7.14% | 6.92% | 5.91% | 4.53% |
CAPEX / EBITDA (%) | 29.28% | 27.55% | 35.79% | - | 24.42% | 23.53% | 19.88% | 15.45% |
CAPEX / FCF (%) | 55.25% | 36.18% | 57.3% | 44.38% | 32.92% | 29.39% | 33.15% | 24.6% |
Items per share | ||||||||
Cash flow per share 1 | 0.2357 | 0.3705 | 0.4473 | 0.4813 | 0.6295 | 0.6485 | 0.7213 | 0.8381 |
Change | - | 57.21% | 20.74% | 7.6% | 30.79% | 3.02% | 11.22% | 16.19% |
Dividend per Share 1 | 0.0527 | 0.0685 | 0.071 | 0.0769 | 0.15 | 0.1598 | 0.1794 | 0.2084 |
Change | - | 30.01% | 3.72% | 8.26% | 95.01% | 6.52% | 12.3% | 16.13% |
Book Value Per Share 1 | 0.7477 | 1.092 | 1.239 | 1.787 | 2.021 | 2.366 | 2.745 | 3.184 |
Change | - | 46.01% | 13.45% | 44.27% | 13.11% | 17.06% | 16% | 16% |
EPS 1 | 0.1568 | 0.1932 | 0.2566 | 0.2807 | 0.3631 | 0.4222 | 0.4923 | 0.5824 |
Change | - | 23.21% | 32.81% | 9.38% | 29.36% | 16.27% | 16.62% | 18.3% |
Nbr of stocks (in thousands) | 88,18,703 | 90,25,341 | 91,30,452 | 93,29,492 | 93,28,411 | 92,97,140 | 92,97,140 | 92,97,140 |
Announcement Date | 28/02/20 | 22/04/21 | 25/04/22 | 25/04/23 | 25/04/24 | - | - | - |
2024 * | 2025 * | |
---|---|---|
P/E ratio | 22.6x | 19.4x |
PBR | 4.03x | 3.47x |
EV / Sales | 3.68x | 3.05x |
Yield | 1.68% | 1.88% |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 300015 Stock
- Financials Aier Eye Hospital Group Co., Ltd.
MarketScreener is also available in this country: United States.
Switch edition